U.S. Markets open in 9 hrs 12 mins
  • S&P Futures

    3,981.75
    +3.75 (+0.09%)
     
  • Dow Futures

    32,348.00
    +29.00 (+0.09%)
     
  • Nasdaq Futures

    12,861.25
    +7.25 (+0.06%)
     
  • Russell 2000 Futures

    1,739.10
    +6.60 (+0.38%)
     
  • Crude Oil

    69.78
    -0.18 (-0.26%)
     
  • Gold

    1,994.60
    -1.30 (-0.07%)
     
  • Silver

    23.23
    -0.03 (-0.11%)
     
  • EUR/USD

    1.0828
    -0.0008 (-0.0758%)
     
  • 10-Yr Bond

    3.4060
    -0.0940 (-2.69%)
     
  • Vix

    22.61
    +0.35 (+1.57%)
     
  • GBP/USD

    1.2278
    -0.0010 (-0.0847%)
     
  • USD/JPY

    130.3610
    -0.4280 (-0.3273%)
     
  • BTC-USD

    28,260.41
    +826.90 (+3.01%)
     
  • CMC Crypto 200

    618.20
    +20.74 (+3.47%)
     
  • FTSE 100

    7,499.60
    -67.24 (-0.89%)
     
  • Nikkei 225

    27,322.69
    -96.92 (-0.35%)
     

Is Gilead Sciences a Good Stock to Buy Now?

Is Gilead Sciences a Good Stock to Buy Now?

Shares of Gilead Sciences (NASDAQ: GILD) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug Administration (FDA) agreed to dramatically increase the addressable patient population for an important cancer drug called Trodelvy. Gilead Sciences splashed out with a $21 billion acquisition of Immunomedics in 2020 for access to Trodelvy.